0001209191-20-031880.txt : 20200522
0001209191-20-031880.hdr.sgml : 20200522
20200522195904
ACCESSION NUMBER: 0001209191-20-031880
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200520
FILED AS OF DATE: 20200522
DATE AS OF CHANGE: 20200522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bujarski Robert Joseph
CENTRAL INDEX KEY: 0001333458
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 20907672
MAIL ADDRESS:
STREET 1: C/O QUIDEL CORPORATION
STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-20
0
0000353569
QUIDEL CORP /DE/
QDEL
0001333458
Bujarski Robert Joseph
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP, NA Comm Ops & Gen Counsel
Common Stock
2020-05-20
4
S
0
20000
189.4141
D
13383
D
The weighted average sale price for these transactions was $189.4141 per share, with a range of $185.705 to $191.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
All transactions reported herein were effected pursuant to a pre-established 10b5-1 trading plan.
Robert J. Bujarski
2020-05-22